16-74774586-TCCTGGCCCGC-TCCTGGCCCGCCCTGGCCCGC

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate

The NM_024306.5(FA2H):​c.160_169dupGCGGGCCAGG​(p.Asp57GlyfsTer48) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000013 in 1,534,250 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Exomes 𝑓: 7.2e-7 ( 0 hom. )

Consequence

FA2H
NM_024306.5 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, single submitter P:1

Conservation

PhyloP100: 5.18

Publications

3 publications found
Variant links:
Genes affected
FA2H (HGNC:21197): (fatty acid 2-hydroxylase) This gene encodes a protein that catalyzes the synthesis of 2-hydroxysphingolipids, a subset of sphingolipids that contain 2-hydroxy fatty acids. Sphingolipids play roles in many cellular processes and their structural diversity arises from modification of the hydrophobic ceramide moiety, such as by 2-hydroxylation of the N-acyl chain, and the existence of many different head groups. Mutations in this gene have been associated with leukodystrophy dysmyelinating with spastic paraparesis with or without dystonia.[provided by RefSeq, Mar 2010]
FA2H Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 35
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-74774586-T-TCCTGGCCCGC is Pathogenic according to our data. Variant chr16-74774586-T-TCCTGGCCCGC is described in ClinVar as Pathogenic. ClinVar VariationId is 242580.Status of the report is criteria_provided_single_submitter, 1 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FA2HNM_024306.5 linkc.160_169dupGCGGGCCAGG p.Asp57GlyfsTer48 frameshift_variant Exon 1 of 7 ENST00000219368.8 NP_077282.3 Q7L5A8-1
FA2HXM_011523317.4 linkc.160_169dupGCGGGCCAGG p.Asp57GlyfsTer48 frameshift_variant Exon 1 of 6 XP_011521619.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FA2HENST00000219368.8 linkc.160_169dupGCGGGCCAGG p.Asp57GlyfsTer48 frameshift_variant Exon 1 of 7 1 NM_024306.5 ENSP00000219368.3 Q7L5A8-1
FA2HENST00000567683.5 linkn.160_169dupGCGGGCCAGG non_coding_transcript_exon_variant Exon 1 of 5 2 ENSP00000455126.1 H3BP32

Frequencies

GnomAD3 genomes
AF:
0.00000658
AC:
1
AN:
152090
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
7.24e-7
AC:
1
AN:
1382160
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
683850
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29800
American (AMR)
AF:
0.0000275
AC:
1
AN:
36308
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24506
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33582
South Asian (SAS)
AF:
0.00
AC:
0
AN:
77696
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35548
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4916
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1082060
Other (OTH)
AF:
0.00
AC:
0
AN:
57744
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000658
AC:
1
AN:
152090
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74292
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41430
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10608
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67974
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Spastic paraplegia Pathogenic:1
Feb 21, 2020
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been observed in individual(s) with hereditary spastic paraplegia (PMID: 25732363, 29376581). This sequence change creates a premature translational stop signal (p.Asp57Glyfs*48) in the FA2H gene. It is expected to result in an absent or disrupted protein product. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. Loss-of-function variants in FA2H are known to be pathogenic (PMID: 20853438, 25496456, 25732363, 26344562). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
5.2
Mutation Taster
=114/186
disease causing

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs794729214; hg19: chr16-74808484; API